152 related articles for article (PubMed ID: 27556512)
1. Coupling of LETM1 up-regulation with oxidative phosphorylation and platelet-derived growth factor receptor signaling via YAP1 transactivation.
Lee J; Lee WK; Seol MY; Lee SG; Kim D; Kim H; Park J; Jung SG; Chung WY; Lee EJ; Jo YS
Oncotarget; 2016 Oct; 7(41):66728-66739. PubMed ID: 27556512
[TBL] [Abstract][Full Text] [Related]
2. New players in high fat diet-induced obesity: LETM1 and CTMP.
Park J; Li Y; Kim SH; Yang KJ; Kong G; Shrestha R; Tran Q; Park KA; Jeon J; Hur GM; Lee CH; Kim DH; Park J
Metabolism; 2014 Mar; 63(3):318-27. PubMed ID: 24333006
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of thyroid carcinoma cells with YAP1 protein interference and its mechanism.
Huang CY; Han Z; Li X; Xie HH; Zhu SS
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2351-2355. PubMed ID: 29762852
[TBL] [Abstract][Full Text] [Related]
4. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
[TBL] [Abstract][Full Text] [Related]
5. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
6. Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis.
Kang W; Tong JH; Chan AW; Lee TL; Lung RW; Leung PP; So KK; Wu K; Fan D; Yu J; Sung JJ; To KF
Clin Cancer Res; 2011 Apr; 17(8):2130-9. PubMed ID: 21346147
[TBL] [Abstract][Full Text] [Related]
7. FGF8 promotes colorectal cancer growth and metastasis by activating YAP1.
Liu R; Huang S; Lei Y; Zhang T; Wang K; Liu B; Nice EC; Xiang R; Xie K; Li J; Huang C
Oncotarget; 2015 Jan; 6(2):935-52. PubMed ID: 25473897
[TBL] [Abstract][Full Text] [Related]
8. Platelet-derived growth factor regulates YAP transcriptional activity via Src family kinase dependent tyrosine phosphorylation.
Smoot RL; Werneburg NW; Sugihara T; Hernandez MC; Yang L; Mehner C; Graham RP; Bronk SF; Truty MJ; Gores GJ
J Cell Biochem; 2018 Jan; 119(1):824-836. PubMed ID: 28661054
[TBL] [Abstract][Full Text] [Related]
9. The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer.
Lu T; Li Z; Yang Y; Ji W; Yu Y; Niu X; Zeng Q; Xia W; Lu S
Cancer Lett; 2018 Jun; 423():36-46. PubMed ID: 29452146
[TBL] [Abstract][Full Text] [Related]
10. PKCι regulates nuclear YAP1 localization and ovarian cancer tumorigenesis.
Wang Y; Justilien V; Brennan KI; Jamieson L; Murray NR; Fields AP
Oncogene; 2017 Jan; 36(4):534-545. PubMed ID: 27321186
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
Zhong X; Lü M; Wan J; Zhou T; Qin B
Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
[TBL] [Abstract][Full Text] [Related]
12. LncRNA SNHG15 acts as a ceRNA to regulate YAP1-Hippo signaling pathway by sponging miR-200a-3p in papillary thyroid carcinoma.
Wu DM; Wang S; Wen X; Han XR; Wang YJ; Shen M; Fan SH; Zhang ZF; Shan Q; Li MQ; Hu B; Lu J; Chen GQ; Zheng YL
Cell Death Dis; 2018 Sep; 9(10):947. PubMed ID: 30237435
[TBL] [Abstract][Full Text] [Related]
13. Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway.
Liao T; Wen D; Ma B; Hu JQ; Qu N; Shi RL; Liu L; Guan Q; Li DS; Ji QH
Oncotarget; 2017 Feb; 8(7):11719-11728. PubMed ID: 28036290
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of LETM1 and CTMP synergistically inhibits tumor growth in H-ras12V liver cancer model mice.
Shin JY; Chung YS; Kang B; Jiang HL; Yu DY; Han K; Chae C; Moon JH; Jang G; Cho MH
Cancer Gene Ther; 2013 Mar; 20(3):186-94. PubMed ID: 23392203
[TBL] [Abstract][Full Text] [Related]
15. Suppression of LETM1 inhibits the proliferation and stemness of colorectal cancer cells through reactive oxygen species-induced autophagy.
Che N; Yang Z; Liu X; Li M; Feng Y; Zhang C; Li C; Cui Y; Xuan Y
J Cell Mol Med; 2021 Feb; 25(4):2110-2120. PubMed ID: 33314691
[TBL] [Abstract][Full Text] [Related]
16. LETM1 is a potential cancer stem-like cell marker and predicts poor prognosis in colorectal adenocarcinoma.
Piao L; Feng Y; Yang Z; Qi W; Li H; Han H; Xuan Y
Pathol Res Pract; 2019 Jul; 215(7):152437. PubMed ID: 31101574
[TBL] [Abstract][Full Text] [Related]
17. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
[TBL] [Abstract][Full Text] [Related]
18. Suppression of LETM1 by siRNA inhibits cell proliferation and invasion of bladder cancer cells.
Huang B; Zhang J; Zhang X; Huang C; Hu G; Li S; Xie T; Liu M; Xu Y
Oncol Rep; 2017 Nov; 38(5):2935-2940. PubMed ID: 29048663
[TBL] [Abstract][Full Text] [Related]
19. TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1.
Tang JY; Yu CY; Bao YJ; Chen L; Chen J; Yang SL; Chen HY; Hong J; Fang JY
Cell Cycle; 2018; 17(1):102-109. PubMed ID: 29157094
[TBL] [Abstract][Full Text] [Related]
20. HMGB1-RAGE signaling facilitates Ras-dependent Yap1 expression to drive colorectal cancer stemness and development.
Qian F; Xiao J; Gai L; Zhu J
Mol Carcinog; 2019 Apr; 58(4):500-510. PubMed ID: 30456802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
